Warner Chilcott Sues Mylan To Block Generic Lo Loestrin

Law360, New York (November 1, 2013, 1:52 PM EDT) -- Warner Chilcott Co. LLC launched suit in New Jersey federal court Wednesday alleging Mylan Inc. has infringed its patent for oral contraceptive Lo Loestrin Fe by seeking federal approval to launch a generic version of the birth control before Warner’s patent expires.

Warner Chilcott claims Mylan subsidiary Famy Care Ltd. has filed an abbreviated new drug application with the U.S. Food and Drug Administration seeking approval to manufacture and market a generic version of Lo Loestrin Fe before Warner Chilcott’s patent covering the contraceptive’s dosing regimen...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.